Executive Summary
Across 18 US SEC filings for the period, the dominant theme is a sharp divergence between a small cohort of operating companies with real revenue momentum (Zicix's FY2026 revenue up 943% to $730,563, NextTrip six-month revenue up 122.9% to $1,998,422, Alphega's first recorded services revenue of $40,575) and a larger group of shell, SPAC, and micro-cap issuers whose losses are being funded by related-party loans, convertible notes, or stock issuance.
Large-cap Marsh & McLennan showed steady top-line growth (Q3 revenue up 8.1% to $6,863 Million) but operating income grew only 3.9% and nine-month operating cash flow fell 26.2%, indicating margin pressure. The most material distress signals came from Laredo Oil (stockholders' deficit of $13,796,134 against $939,375 in total assets), Greystone Logistics (quarterly sales down 50.4% with a gross loss of $778,804 and a current-liability-driven working capital deficit of $8,761,289), FingerMotion (quarterly revenue down 96.8% YoY with a $3,980,797 credit impairment), and Biomerica (gross margin compressing from roughly 31% to roughly 8%). Several filings show earnings improvements that are non-operating in nature, including Cannabis Suisse's net income driven entirely by $114,739 of debt-premium amortization and Plutonian's SPAC trust income, so headline net income should not be read as operating improvement. Overall the stream points to continued liquidity stress and dilution risk across micro-caps, with the few revenue-growth stories requiring verification of collectability and sustainability.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 10-K · 10-Q
Tracking the trend? Catch up on the prior US Earnings Financial Results SEC Filings digest from October 14, 2026.
Investment Signals (12)
- Zicix Corp ↓ (BULLISH)▲
FY2026 (Mar 31) revenue rose 943% YoY to $730,563 from $70,068, and net loss from continuing operations narrowed 43% to $1,388,179 from $2,447,184
-
Six-month revenue rose 122.9% to $1,998,422 from $896,475 and six-month net loss narrowed to $(6,849,152) from $(7,355,388), though net cash used in operations rose roughly tenfold to $(4,803,656) [MIXED - leaning BEARISH on cash]
- Alphega Innovations Corp ↓ (BEARISH)▲
First recorded services revenue of $40,575 for nine months, but net loss widened to $6,178,733 from $1,414,570, including a $2,300,000 non-cash stock compensation charge
- Greystone Logistics (GLGI) (BEARISH)▲
Quarterly sales fell 50.4% YoY to $5,321,088 and gross profit swung to a $(778,804) loss from a $503,555 profit; net loss of $2,558,995 vs $1,099,022
- FingerMotion, Inc. ↓ (BEARISH)▲
Quarterly revenue fell 96.8% YoY to $281,076 and six-month net loss attributable to stockholders nearly doubled to $(6,932,566); cash rose to $2,135,825 only via a $5.6M convertible note
- Biomerica Inc ↓ (BEARISH)▲
Net sales fell 8.3% to $1,265,000 and gross profit fell 75.7% to $103,000, with gross margin compressing to roughly 8% from roughly 31%; quarterly net loss of $1,232,000 vs prior-year income of $2,000
- Marsh & McLennan Companies ↓ (MIXED)▲
Q3 revenue rose 8.1% to $6,863 Million and diluted EPS rose to $1.69 from $1.51, but nine-month operating income fell 2.7% and operating cash flow fell 26.2% to $2,313 Million
- Cannabis Suisse Corp. (CSUI) ↓ (BEARISH)▲
Quarterly net income of $55,127 (up 296%) is entirely attributable to $114,739 of debt-premium amortization; excluding it the company would show a loss of roughly $59,600, with $107,000 of related-party lease liabilities in default
- Plutonian Acquisition Corp. II ↓ (MIXED)▲
Quarterly net income of $711,573 driven by $967,381 of Trust Account interest, while G&A rose from $17,250 to $259,473 and operating cash use rose to $314,349 from $41,707
- Dankon Corp ↓ (BULLISH)▲
Quarterly revenue more than doubled to $21,027 from $9,581 and six-month revenue reached $54,694, with six-month net loss narrowing to $5,710 from $37,444 and operating cash outflow narrowing to $(3,413) from $(46,068)
- Laredo Oil, Inc. ↓ (BEARISH)▲
Consulting and professional services jumped to $883,563 from $117,562 and net loss widened to $1,605,030 from $952,074 against zero revenue; the company raised $500,500 through common stock sales
-
Nine-month net loss widened to $1,353,995 from $409,659 as trust interest income collapsed to $3,809 from $398,754; a subsequent-event business combination created Bradbury Capital Inc.
Risk Flags (10)
- Laredo Oil/Balance Sheet Insolvency↓ [HIGH RISK]▼
Total liabilities of $14,735,509 against $939,375 in total assets, stockholders' deficit of $13,796,134, accumulated deficit of $35.48M, accrued payroll of $3,825,469 and accrued interest of $801,512 continuing to build
- Greystone Logistics/Liquidity↓ [HIGH RISK]▼
Working capital deficit of $8,761,289 driven by $9,790,703 of current long-term debt and a $2,200,000 revolver reclassified as current; total equity fell to $8,958,591 from $11,517,586; cash only $360,533
- FingerMotion/Revenue Collapse and Impairment↓ [HIGH RISK]▼
Revenue down 94.6% over six months to $931,165 from $17,106,254, with a $3,980,797 credit impairment loss in the quarter and dependence on a $5.6M convertible note for operating cash outflow of $(3,490,279)
- Zicix Corp/Deteriorating Current Quarter↓ [HIGH RISK]▼
Zero revenue in Q1 FY2027 vs $300,869 prior year, net loss up 244.8% to $653,617, cash at $0, stockholders' deficit deepened to $(2,884,777), and $79,983 plant write-off; the FY2026 revenue headline is not sustaining
- Zicix Corp/Collectability↓ [MEDIUM RISK]▼
The $430,027 cloud consulting revenue equals the accounts receivable impairment amount exactly, raising questions about the quality of reported revenue
- Alphega Innovations/Dilution and Deficit↓ [HIGH RISK]▼
Stockholders' deficit expanded to $(5,744,827), total liabilities $5,760,999, legal and professional fees $3,182,960 for nine months (vs $1,268,288), and $(0.23) per-share quarterly loss
- Biomerica/Margin and Income Quality↓ [MEDIUM RISK]▼
Gross margin fell to roughly 8% from roughly 31%, and prior-year net income was supported by $1,123,000 of dividend and interest income that nearly disappeared ($1,000) this quarter; operating cash burn rose to $802,000 from $268,000
- Cannabis Suisse/Related-Party Default↓ [MEDIUM RISK]▼
$107,000 of operating lease liabilities to related parties in default; rental revenue of $21,000 produced a $931 gross loss; reported profit is non-cash
- Outstanding Share Dilution/Micro-caps [MEDIUM RISK]▼
Longevity Diversified (UBUYHOLDINGS) weighted shares rose roughly twentyfold to 568,735,798 from 28,436,782 YoY; Londax Corp. recorded $368,547 professional fees with zero assets and a $(16,774) deficit, funded by S-8 and debt-conversion share issuances
- NextTrip/Operating Cash Burn↓ [MEDIUM RISK]▼
Net cash used in operations rose to $(4,803,656) from $(470,283) with a $(479,315) deferred revenue reduction, and a newly recorded $154,333 credit loss provision alongside related-party receivable increase; cash fell to $1,145,136
Opportunities (8)
-
FY2026 product sales up 329% to $300,536 and cloud consulting launched at $430,027; loss narrowed 43%, and the absence of FY2025 goodwill impairment ($1,376,083) and discontinued-ops loss ($847,234) could support a re-rating if quarterly revenue recovers [OPPORTUNITY - speculative]
-
Six-month revenue up 122.9% with cash of $1,145,136; if the stock-based compensation credit of $(13,660) reflects reduced dilution and deferred revenue normalizes, the company's net loss improvement may continue [OPPORTUNITY - needs cash-burn monitoring]
-
Quarterly revenue up 119% YoY and operating cash outflow down 93% for six months; amortization growth reflects recent intangible asset additions, and accounts payable fell to $200 from $13,250, suggesting improved working-capital discipline [OPPORTUNITY - micro-cap, high risk]
-
Q3 diluted EPS of $1.69 vs $1.51 (+12%) and revenue up 8.1% despite operating expense growth of 9.0%; if expense growth moderates toward revenue growth, operating leverage could return, and nine-month income tax expense declined only 5.2% [OPPORTUNITY - large cap, watch margin]
-
Subsequent-event combination with PubCo renamed Bradbury Capital Inc. creates a potential catalyst; cash of $7,681 and nine-month loss per share of $(0.40) require careful analysis of the post-merger capital structure [OPPORTUNITY - event-driven]
-
Trust Account holds $100,786,509 with $286,509 of quarterly interest income; the $4,937,619 accretion charge indicates redemption-value accounting, and the trust balance provides a reference point for any business-combination outcome [OPPORTUNITY - SPAC arbitrage, timing-dependent]
-
Trust Account interest of $967,381 in the quarter produced net income of $711,573 and accumulated retained earnings of $217,914 vs a deficit of $81,554 at February 28, 2026; trust yield is currently the primary earnings driver [OPPORTUNITY - SPAC yield, monitor operating burn]
-
Debt-premium amortization of $114,739 and first rental income suggest a diversifying revenue base; resolution of $107,000 in related-party lease defaults would materially improve the balance sheet [OPPORTUNITY - speculative]
Sector Themes (6)
- Shell and Micro-cap Cash Funding via Related Parties and Converts (BEARISH SECTOR)◆
At least 7 filings (Zicix, Cannabis Suisse, UBUYHOLDINGS, WEWARDS, Dankon, Londax, Laredo) depend on related-party loans, CEO-contributed capital, or convertible notes for operations, with WEWARDS ending the quarter at zero cash and Londax at zero assets; this pattern signals structural dependence on insider support rather than operating cash generation
- SPAC Income Masking Operating Losses (MIXED SECTOR)◆
Plutonian ($967,381 trust interest vs $259,473 G&A), East West Ave ($286,509 trust interest vs $118,345 operating costs), and Technology & Telecommunication (trust income of $3,809 vs operating costs of $1,357,804) illustrate that SPAC net results are highly dependent on trust yields and prevailing rate environment; the TETUF filing shows the income reversal when trust balances shrink
- Revenue Volatility and Collectability Concerns (BEARISH SECTOR)◆
FingerMotion (-96.8% quarterly), Greystone (-50.4%), Biomerica (-8.3%), Zicix (from $300,869 to zero) and NextTrip (-27.8% quarterly but +122.9% six-month) show that revenue trends are highly uneven; provisions for credit loss, impairments and receivable write-downs appeared in Zicix, FingerMotion, NextTrip and Cannabis Suisse, suggesting collection stress is widespread
- Non-cash Items Driving Reported Earnings (CAUTION)◆
Cannabis Suisse's profit is debt amortization, Plutonian and East West Ave depend on trust income, Alphega's loss includes a $2,300,000 stock compensation charge, and Londax's cash burn was offset by S-8 share issuance; investors should separate operating performance from accounting and financing effects
- Large-cap Margin Pressure Despite Top-line Growth (MIXED)◆
Marsh & McLennan's operating expenses (+9.0%) outpaced revenue (+8.1%), other operating expenses rose 22.0%, interest expense rose to $738 Million, and nine-month operating cash flow fell 26.2%; the same pattern (revenue growth, cost growth faster) is visible in Biomerica's gross margin compression
- Going-concern and Working-capital Deficits Across Smaller Issuers (BEARISH SECTOR)◆
Laredo (current liabilities $13.83M vs current assets $224,338), Greystone (working capital deficit $8,761,289), Zicix (working capital deficit approx. $2.9M), Alphega (stockholders' deficit $(5,744,827)) and Longevity (deficit $(155,641)) indicate broad liquidity strain that could drive further dilution or restructuring
Watch List (8)
-
Q1 FY2027 revenue was zero versus $300,869 prior year; monitor whether the $430,027 cloud consulting revenue is collected and whether the company can fund operations beyond the $390,000 private placement; next filing is the Q2 FY2027 10-Q
- Greystone Logistics (GLGI)👁
$9,790,703 of current long-term debt and a $2,200,000 revolver classified as current require refinancing; monitor covenant status and the Q2 FY2027 filing for gross margin recovery from the $(778,804) gross loss
-
Accrued payroll ($3,825,469) and accrued interest ($801,512) continue to build; watch for going-concern language in the next filing, any reverse-merger or asset sale, and continued common stock sales
-
Revenue has collapsed 96.8% YoY; watch for the $5.6M convertible note's conversion terms, further credit impairments, and whether operating cash outflow of $(3,490,279) can be reduced
- Marsh & McLennan Companies (MMC)👁
Monitor Q4 2026 operating expense trajectory versus revenue growth, interest expense trend ($738 Million nine-month), and whether operating cash flow recovers from the 26.2% nine-month decline
-
Track closing of the subsequent-event business combination, post-merger capital structure, and the status of trust redemptions; trust income has fallen from $398,754 to $3,809 for nine months
-
Net cash used in operations of $(4,803,656) against $1,145,136 in cash implies a short runway; watch for capital raises, deferred revenue normalization, and whether the $154,333 provision for credit loss grows
-
Monitor whether legal and professional fees ($3,182,960 nine-month) and the $2,300,000 stock compensation charge continue, given the stockholders' deficit of $(5,744,827) and $(0.23) quarterly loss per share
Filing Analyses
(18)
15-10-2026
Zicix Corp's annual report for the year ended March 31, 2026 shows revenue rising 943% YoY to $730,563 from $70,068, driven by new cloud consulting services ($430,027) and product sales growth ($300,536, up 329%). However, the company remains loss-making: net loss from continuing operations was $1,388,179 (versus $2,447,184 prior year, an improvement of 43%), while G&A expenses rose 53% to $1,326,751 and a $430,027 impairment on accounts receivable was recorded. The filing also flags substantial PRC/Hong Kong regulatory, currency-conversion, and dividend-restriction risks tied to its holding-company structure.
- · Net loss narrowed to $1,388,179 from $3,294,418 on a total basis, helped by the absence of FY2025's $847,234 discontinued operations loss and a $567,656 fair-value gain on convertible debts
- · Goodwill impairment of $1,376,083 in FY2025 did not recur in FY2026
- · Revenue includes $430,027 from cloud consulting services, the same amount as the accounts receivable impairment, which warrants scrutiny of collectability
- · Cost of revenue rose 3,067% to $480,461, outpacing revenue growth, so gross margin compressed to roughly 34% from about 78% in FY2025
- · Interest expense on bonds, convertible debts and promissory notes rose 60% to $423,902
- · Filing discloses material PRC/Hong Kong risks: possible restrictions on moving cash out of Hong Kong, PRC control over currency conversion, potential CSRC/US-listing approval requirements, EIT Law resident-enterprise classification, and PRC data-security rules
15-10-2026
Cannabis Suisse Corp. (CSUI) reported a net income of $55,127 for the quarter ended August 31, 2026, versus $13,907 in the prior-year quarter, a 296% increase. However, this improvement came from a non-operating item: the $114,739 amortization of debt premium. The company generated first-ever rental income of $21,000 from a related party but posted a gross loss of $931 on that revenue and an operating loss of $43,315, with operating expenses down 50% YoY from $84,535 to $42,384.
- · Net income was entirely driven by $114,739 of non-cash amortization of debt premium, offsetting a $43,315 operating loss and $16,297 related-party interest expense; excluding this item, the company would have posted a loss of roughly $59,600.
- · Rental income of $21,000 from a related party produced a gross loss of $931 after $21,931 cost of rental revenue, so the new revenue line is not yet margin-positive.
- · Operating lease liabilities of $107,000 to related parties remain in default.
- · Cash fell to $256 at August 31, 2026, with $13,000 net repaid to related-party advances during the quarter, indicating reliance on related-party funding.
- · Operating cash flow turned positive at $12,780, but this was supported by working-capital changes and lease cost adjustments rather than core earnings.
- · Diluted share count of 213,419,658 includes 142,738,720 shares from convertible notes and accrued interest, representing substantial potential dilution against 70,680,938 basic shares.
15-10-2026
Zicix Corp reported no revenue for the three months ended June 30, 2026, versus $300,869 in the prior-year quarter (a 100% decline), while G&A expenses rose 90.6% to $522,109. The net loss widened to $653,617 from $189,582 (up 244.8%), and stockholders' deficit deepened to $(2,884,777) from $(2,619,762) at March 31, 2026. Positive offsets were limited to a $390,000 private placement and a reduction in cash burn versus the prior year's operating outflow, although cash ended the quarter at zero.
- · Cash and cash equivalents fell to $0 at June 30, 2026, from $2,716 a year earlier, with operations funded entirely by the $390,000 private placement and related-party advances.
- · Plant and equipment of $79,983 was written off in Q2 2026, adding to the non-operating loss alongside $46,183 of bond/convertible interest expense.
- · Accumulated deficit reached $(6,355,869), and working capital deficit widened to approximately $(2.9) million (current liabilities of $3,582,653 vs current assets of $498,679).
- · Convertible debts and related instruments remain significant: current convertible debts of $1,041,318 and a new convertible promissory note of $183,138 classified as current.
- · Management's going concern exposure is implied by the stockholders' deficit, zero cash balance, and reliance on dilutive financing; the filing also flags material PRC/Hong Kong regulatory and dividend-transfer risks tied to the holding company structure.
15-10-2026
Longevity Diversified Holdings, Inc. (filed under UBUYHOLDINGS INC) reported a net loss of $20,784 for the three months ended August 31, 2026, compared with a net loss of $20,308 in the prior-year quarter, an increase of 2.3%. The company has no revenue, and its stockholders' deficit widened to $(155,641) from $(134,857) at May 31, 2026, as related-party notes payable rose to $153,616.
- · No revenue was reported in either period; the company's losses consist solely of general and administrative expenses.
- · Operating cash outflows were funded entirely by related-party notes payable, which increased by $30,819 in the quarter.
- · Weighted average shares outstanding rose roughly twentyfold to 568,735,798 from 28,436,782 year over year, causing per-share loss to round to $(0.00) in both periods.
- · Accumulated deficit reached $(14,369,200), and the company holds no cash at either balance sheet date.
15-10-2026
Laredo Oil reported no revenue for the quarter ended August 31, 2026, versus $1,543 in the prior-year quarter, as total operating expenses rose 117% to $1,471,158, driven by consulting and professional services that jumped from $117,562 to $883,563. The net loss widened to $1,605,030 (from $952,074), and total liabilities grew to $14,735,509 against only $939,375 in total assets, leaving a stockholders' deficit of $13,796,134. Cash fell to $147,211, down from $420,676 at fiscal year-end, while the company raised $500,500 through common stock sales.
- · Going-concern pressure is evident: current liabilities of $13.83M far exceed current assets of $224,338, and accumulated deficit reached $35.48M.
- · Accrued payroll liabilities rose to $3,825,469 and accrued interest to $801,512, both continuing to build up unpaid obligations.
- · Accounts payable increased to $3,287,939 from $2,813,598, a rise of about $474K in the quarter.
- · Operating cash burn of $821,436 was funded mainly by $500,500 in equity sales and $143,000 in bridge loans.
- · Interest expense fell to $133,872 from $276,162, largely reflecting lower amortization of debt discount ($17,003 vs. $113,803).
- · Property and equipment, net declined to $61,812 from $67,172 due to depreciation.
- · Stock-based compensation of $22,904 and stock issued for services of $215,000 were recorded as non-cash expenses.
15-10-2026
Plutonian Acquisition Corp. II, a special purpose acquisition company, reported net income of $711,573 for the three months ended August 31, 2026, versus a net loss of $16,366 in the prior-year quarter, driven by $967,381 of interest earned on its Trust Account. For the six months, net income was $933,250 compared with a net loss of $61,790 a year earlier. Operating costs rose sharply, with general and administrative expenses of $259,473 for the quarter (up from $17,250) and $365,491 for the six months (up from $63,233), so trust income rather than operations drove the improvement.
- · Trust Account income is the sole source of the swing to net income; operating expenses rose roughly 15x for the quarter and nearly 6x for the six months.
- · Net cash used in operating activities was $314,349 for the six months, versus $41,707 a year earlier, reflecting higher operating spend.
- · Accumulated retained earnings were $217,914 as of August 31, 2026, versus an accumulated deficit of $81,554 at February 28, 2026.
- · Total shareholders' equity turned positive at $218,245 from a deficit of $56,554 at February 28, 2026.
- · Cash and cash equivalents rose to $270,975 from $49,273 at February 28, 2026, while current liabilities fell to $72,980 from $206,000, including repayment of a $200,000 related-party promissory note.
15-10-2026
NextTrip, Inc. (NTRP) reported Q2 FY2026 (three months ended August 31, 2026) revenue of $546,687, down 27.8% from $757,648 in the prior-year quarter, while the net loss widened 28.5% to $(3,723,683) from $(2,898,155). Six-month revenue rose to $1,998,422 from $896,475 (+122.9%), but the six-month net loss narrowed to $(6,849,152) from $(7,355,388), helped by a large decline in organization costs. Cash fell to $1,145,136 at period end, and net cash used in operations was $(4,803,656) versus $(470,283) a year earlier.
- · Stock-based compensation turned to a $(13,660) credit in the six months versus $138,325 expense a year earlier.
- · Provision for credit loss of $154,333 (six months) was newly recorded, alongside a $154,333 related-party receivable increase.
- · Net cash used in operations rose roughly tenfold to $(4,803,656), driven by a $(479,315) deferred revenue reduction versus a $2,000,939 increase a year earlier.
- · Q2 FY2026 operating expenses rose 3.7% to $3,493,131, led by salaries and benefits (+41.3%) and depreciation and amortization (+55.4%).
- · Six-month interest expense rose to $902,633 from $564,612, and cash interest paid rose to $357,626 from $90,383.
- · A $296,242 non-cash warrant revaluation gain helped narrow other expense in Q2 FY2026, partly offset by a $(39,285) warrant transaction cost.
15-10-2026
FingerMotion reported a sharp revenue decline for the quarter ended August 31, 2026, with revenue of $281,076 versus $8,647,511 a year earlier (-96.8% YoY), and six-month revenue of $931,165 versus $17,106,254 (-94.6%). Net loss attributable to stockholders widened to $(4,932,239) from $(1,541,010) in the prior-year quarter, driven primarily by a $3,980,797 credit impairment loss, while a $1,184,221 gain on derivative liabilities partially offset operating losses. Gross profit improved modestly in the quarter to $136,515 from $38,740, and the company's cash balance rose to $2,135,825 on a $5.6 million convertible note.
- · Operating cash outflow of $(3,490,279) for six months was funded primarily by a $5.6M convertible promissory note, with cash ending at $2,135,825 versus $221,836 a year earlier.
- · Six-month net loss attributable to stockholders was $(6,932,566), compared with $(3,549,566) in the prior-year period, nearly doubling.
- · Amortization of debt discount of $(626,505) in the quarter reflects the convertible note financing cost.
- · Stockholders' equity declined to $11,288,899 at August 31, 2026 from $15,187,650 at March 1, 2026, with an accumulated deficit of $(48,117,720).
- · Interest paid for the six months rose to $735,180 from $92,129 a year earlier.
- · Credit impairment losses for the six months totaled $(4,503,743) versus $(236,769) in the prior-year period, indicating heightened receivable collectability concerns.
- · Variable Interest Entity liabilities ($14.9M) exceed VIE assets ($9.6M), and the VIE's subsidiaries show liabilities of $49.7M against assets of $43.9M.
15-10-2026
BIOMERICA INC reported a net loss of $1,232,000 for the three months ended August 31, 2026, compared with net income of $2,000 in the prior-year quarter, as net sales fell 8.3% to $1,265,000 and gross profit dropped 75.7% to $103,000. Cash rose to $2,733,000 from $1,308,000 on a $2,231,000 private placement, but operating cash burn widened to $802,000 from $268,000 and the prior-year quarter benefited from $1,123,000 of dividend, interest, and other income.
- · Gross margin compressed to roughly 8% from roughly 31% a year earlier as cost of sales rose while net sales declined.
- · Prior-year net income was supported by $1,123,000 of dividend, interest, and other income that nearly disappeared in the 2026 quarter ($1,000).
- · Inventory reserves fell to $370,000 from $394,000, and gross inventory decreased to $2,004,000 from $2,101,000.
- · A $500,000 secured promissory note payable to a related party remains classified as a current liability.
- · Accrued common stock issuance costs of $111,000 were charged against additional paid-in capital and remained unpaid at quarter end.
- · Operating lease liabilities total $1,826,000 (current $240,000 plus non-current $1,586,000) against right-of-use assets of $1,809,000.
- · The filing lists risk-related forward-looking considerations including the ability to access capital and debt markets and SEC limits on equity issuance capacity.
15-10-2026
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH) reported a Q1 FY2027 net loss of $206,876 for the three months ended August 31, 2026, versus a restated $745,208 loss in the prior-year quarter, a 72% reduction in losses. Revenue remained zero in both periods, and total shareholders' deficit widened to $(543,336) from $(383,567) at May 31, 2026, as total liabilities rose to $1,379,539 and cash increased to $141,579 mainly from new convertible note proceeds.
- · Zero revenue in both periods; the company has no reported sales.
- · Sales and marketing expense of $67,262 and professional fees of $58,790 were the largest operating cost lines after management and labor ($53,374); no R&D spend was recorded versus $307,605 in the prior-year quarter.
- · Interest expense rose to $6,495 from $13, reflecting new convertible note borrowings.
- · Current liabilities of $1,329,539 far exceed cash of $141,579, implying a significant working-capital deficit.
- · Operating cash flow was positive $22,096 versus negative $74,801 a year earlier, but this was driven by increases in accounts payable and related-party accruals rather than operating earnings.
- · Software development in process grew to $526,938 from $398,008, and property and equipment, net rose to $694,624.
15-10-2026
East West Ave Acquisition Corp., a SPAC, reported net income of $136,744 for the three months ended August 31, 2026 and $118,199 for the nine months, driven by $286,509 of interest earned on its Trust Account, which holds $100,786,509 at period end. Operating costs were $118,345 for the quarter and $136,890 for the nine months, and the company recorded $31,420 in income tax expense. Net loss including accretion and remeasurement of redeemable common stock was $(5,087,384) for the quarter and $(5,105,929) for the nine months, reflecting a $4,937,619 accretion charge.
- · Net loss per share for non-redeemable common stock was $(0.88) for the quarter and $(1.42) for the nine months, while redeemable common stock showed positive per-share income of $0.77 and $3.52 respectively
- · Nine-month non-redeemable net loss was $(3,602,779), largely offset in the allocation by the redeemable stock's positive income allocation of $3,720,978 after accretion and remeasurement
- · Accretion of carrying value to redemption value of $4,937,619 materially reduced shareholder equity and drove the comprehensive net loss figures
- · Operating costs rose from $118,345 in the quarter to $136,890 for the nine months, indicating only $18,545 of operating expenses in the earlier six-month period
- · Interest income of $286,509 on the Trust Account is the sole source of other income and the primary driver of reported net income
- · Cash flow from operations was negative $(211,623) for the nine months, while financing inflows of $101,375,914 funded the Trust Account and working capital
- · Redemption value per share was $10.08 as of August 31, 2026, with 10,000,000 public shares subject to possible redemption
15-10-2026
Dankon Corp reported Q2 FY2027 (three months ended August 31, 2026) revenue of $21,027, up from $9,581 in the prior-year quarter, and a net loss of $16,686, narrowing from $23,642 a year earlier. For the six months, revenue rose to $54,694 from $9,581 and the net loss narrowed to $5,710 from $37,444. However, the company remains in a stockholders' deficit of $(6,020), up from $(310) at February 28, 2026, and reliance on related-party loans increased to $95,080.
- · Total operating expenses rose to $37,713 in Q2 from $33,223, driven by amortization growth from $3,557 to $6,069 following intangible asset additions.
- · Operating cash outflow for six months narrowed to $(3,413) from $(46,068), but the company still relied on $10,350 in related-party loan proceeds and had no equity raise in the period.
- · Prepaid expenses fell from $21,493 to $6,592 and the $13,050 project in progress was cleared; accounts payable dropped from $13,250 to $200.
- · Deferred revenue declined from $28,427 to $16,903, a 40.6% decrease that may signal lower customer prepayments going forward.
- · Six-month revenue of $54,694 implies Q1 FY2027 revenue of about $33,667, indicating the quarter-over-quarter trajectory is uneven across the period.
- · Cash fell to $3,621 with minimal liquidity relative to $112,183 in total current liabilities, leaving a working capital deficit of about $101,970.
15-10-2026
WEWARDS, INC. (WEWA) reported no revenue and a net loss of $20,150 for the three months ended August 31, 2026, versus a net loss of $159,009 in the prior-year quarter, an improvement of $138,859 driven mainly by the absence of related-party interest expense ($132,329 in the prior year) and lower professional fees. Total assets fell to $75 from $300, and the company ended the quarter with no cash, with operating expenses covered by its CEO through contributed capital.
- · Revenue was nil in both periods, so the company has no operating revenue to offset expenses.
- · Related-party interest expense of $132,329 in the prior-year quarter was eliminated, and interest income of $3,300 also disappeared, leaving no other income or expense this quarter.
- · The company had zero cash at August 31, 2026, down from $671,635 a year earlier, and cash used in operations was nil this quarter versus $21,655 in the prior-year period.
- · The CEO paid $20,325 of company expenses that were recorded as contributed capital, a non-cash financing mechanism that is effectively funding operations.
- · Accumulated deficit reached $19,639,131 and stockholders' equity turned slightly positive at $75, from a deficit of $100 at May 31, 2026.
- · Accounts payable was fully cleared ($400 to zero) and prepaid expenses declined from $300 to $75.
- · Share count remained at 107,483,450 with no dilution or new issuances during the period.
15-10-2026
Marsh & McLennan reported Q3 2026 revenue of $6,863 Million, up 8.1% from $6,351 Million in Q3 2025, and diluted EPS of $1.69 versus $1.51. However, operating income rose only 3.9% to $1,215 Million while operating expenses grew 9.0%, and nine-month operating income declined 2.7% to $4,868 Million and net income attributable to the Company fell 3.6% to $3,220 Million. Nine-month operating cash flow dropped 26.2% to $2,313 Million.
- · Operating expenses rose 9.0% in Q3 2026 to $5,648 Million, outpacing revenue growth of 8.1%, with other operating expenses up 22.0% to $1,570 Million
- · Interest expense rose to $738 Million for nine months (vs $725 Million), and income tax expense on the nine-month period fell only 5.2% to $1,027 Million
- · Nine-month non-controlling interest income increased 13.1% to $69 Million, while investment income fell 66.7% to $9 Million
- · Net receivables increased $878 Million (11.4%) to $8,548 Million since December 31, 2025, and short-term debt rose to $1,644 Million from $1,267 Million
- · Net cash from operations fell $818 Million year over year, driven by a $872 Million receivables build, while treasury share purchases reached $2,016 Million for nine months (up from $1,002 Million)
- · Other comprehensive income was positive in Q3 2026 ($61 Million net of tax) but nine-month OCI was negative ($(85) Million) versus $799 Million a year earlier due to foreign currency translation losses
15-10-2026
Londax Corp. (LDXC) reported a net loss of $368,547 for the three months ended August 31, 2026, versus a net loss of $11,943 in the prior-year quarter, driven almost entirely by $368,547 in professional fees. The company has no revenue in either period and holds zero cash and zero total assets at August 31, 2026, with total liabilities of $16,774 and a stockholders' deficit of $(16,774), compared with positive equity of $312 at May 31, 2026. Balanced view: the loss is substantially larger, and the company's balance sheet has moved from a small positive equity position to a deficit, while a related-party debt reduction and a stock-for-debt conversion offset some liabilities.
- · Revenue fell to zero from $3,107 in the prior-year quarter; the company reports no revenue in either period.
- · Operating cash flow was $(352,769) in the current quarter versus a positive $13,996 in the prior-year quarter, with the cash burn fully offset by non-cash equity issuances (S-8 shares and shares issued for debt/expense reimbursement).
- · Related party loans fell from $37,741 at May 31, 2026 to $15,804 at August 31, 2026, following asset relinquishment and debt forgiveness of $(1,308).
- · Prepaid legal fees, mobile app, software development costs, and website assets (total $44,347 at May 31, 2026) were written down to zero by August 31, 2026.
- · Shares outstanding rose 156% from 2,231,135 to 5,350,000 during the quarter, materially diluting existing holders.
- · The filing includes a going-concern-related cautionary statement and notes the lack of a public market for the company's securities.
15-10-2026
Technology & Telecommunication Acquisition Corp (TETUF) reported a net loss of $768,666 for the three months ended August 31, 2026, versus a net loss of $439,778 in the prior-year quarter, a 74.8% increase. For the nine months, the net loss widened to $1,353,995 from $409,659, driven by formation and operating costs rising to $1,357,804 from $808,413 while trust interest income fell sharply to $3,809 from $398,754. The filing also discloses a subsequent-event business combination in which Holdings became a wholly-owned subsidiary of PubCo, with the combined company renamed Bradbury Capital Inc.
- · Nine-month net cash used in operating activities was $248,006 versus $242,170 in the prior year
- · Cash at period end was $7,681 versus $2,653 a year earlier
- · Nine-month basic and diluted loss per share was $(0.40) versus $(0.09)
- · Trust redemptions of $31,974,048 occurred in the prior-year nine months, with only $1,381 withdrawn in 2026
- · Total shareholders' deficit grew to $(11,848,471) at August 31, 2026 from $(10,167,568) a year earlier
- · 10% of Closing Payment Shares are held in escrow with Continental Stock Transfer & Trust to cover indemnification obligations
- · Public Warrants may be redeemed at $0.01 per warrant if the Class A share price equals or exceeds $18.00 over specified trading days
15-10-2026
Greystone Logistics (GLGI) reported a net loss of $2,558,995 for the quarter ended August 31, 2026, versus a net loss of $1,099,022 a year earlier, as sales fell 50.4% to $5,321,088 from $10,732,573 and the company posted a gross loss of $778,804 compared with a gross profit of $503,555 in the prior-year quarter. Total equity declined to $8,958,591 from $11,517,586 at May 31, 2026, and cash fell to $360,533. Accumulated deficit widened to $38,427,630.
- · Working capital turned sharply negative at August 31, 2026: current liabilities of $15,307,840 exceeded current assets of $6,546,551, a deficit of $8,761,289, driven by $9,790,703 of current long-term debt and a $2,200,000 revolver classified as current.
- · Accounts payable and accrued expenses rose to $2,962,704 from $2,273,620, while accounts receivable from related parties increased to $1,374,933 from $1,029,462.
- · Deferred tax liability increased to $5,415,954 from $5,017,814, and the quarter recorded a $398,140 income tax provision versus a $350,672 benefit in the prior-year quarter.
- · Interest expense rose to $281,843 from $229,829 year over year.
- · Inventory of $2,519,945 comprised raw materials of $1,947,606 and finished goods of $572,339.
- · No preferred dividends were paid this quarter versus $1,610 a year earlier, and no common stock repurchases occurred versus $123,147 in the prior-year quarter.
- · Depreciation and amortization declined to $1,396,149 from $1,530,669 year over year.
15-10-2026
Alphega Innovations Corp reported a Q3 FY2026 (three months ended August 31, 2026) net loss of $3,583,901, or $(0.23) per share, versus a net loss of $430,583, or $(0.03) per share, in the prior-year quarter, an increase of roughly 732%. For the nine months ended August 31, 2026, the company generated its first recorded revenue of $40,575 (services income) against none in the prior-year period, but the net loss widened to $6,178,733 from $1,414,570, driven largely by a $2,300,000 non-cash stock-based compensation charge and higher legal and professional fees. Cash rose modestly to $16,172, while total liabilities reached $5,760,999 and the stockholders' deficit expanded to $(5,744,827).
- · Cost of revenue of $(20,146) against $40,575 services income produced a nine-month gross profit of $20,429, versus no gross profit in the prior-year period
- · Consulting expenses rose to $494,275 for nine months (from $132,725) and legal and professional services rose to $3,182,960 (from $1,268,288)
- · A $144,666 loss on settlement of service and $165,672 of common stock issued for services were recorded in the nine months ended Aug 31, 2026
- · Net cash used in operating activities widened to $(241,581) from $(71,627), funded largely by a $3,349,831 increase in amounts due to related parties
- · Cash receipts from common stock sales were $204,683 in the nine-month period, with share count rising to 17,342,354 from 14,670,000 at fiscal year-end
- · Current liabilities of $5,760,999 far exceed total assets of $16,172, and the company's working capital deficit is approximately $5.7 million
- · Financial charges increased to $8,910 for nine months from $1,227, and the three-month period recorded no revenue
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 18 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Earnings Financial Results SEC Filings
October 13, 2026
US Earnings Financial Results SEC Filings — October 13, 2026
October 09, 2026
US Earnings Financial Results SEC Filings — October 09, 2026
October 08, 2026
US Earnings Financial Results SEC Filings — October 08, 2026
October 07, 2026
US Earnings Financial Results SEC Filings — October 07, 2026
🇺🇸 More from United States
View all →October 15, 2026
US Pre-Market SEC Filings Roundup — October 15, 2026
US Pre-Market SEC Filings Roundup
October 15, 2026
US Executive Compensation Proxy SEC Filings — October 15, 2026
US Executive Compensation Proxy SEC Filings
October 15, 2026
US Executive Officer Management Changes SEC — October 15, 2026
US Executive Officer Management Changes SEC
October 15, 2026
US Merger & Acquisition SEC Filings — October 15, 2026
US Merger & Acquisition SEC Filings